Loading stock data…
RDNT
$56.85+0.30 (+0.53%)
Market ClosedLast close May 1
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
RadNet, Inc. in the Healthcare sector is trading at $56.85. The stock is currently near its 52-week low of $50.76, remaining 18.2% below its 200-day moving average. Technical signals show neutral RSI of 52 and bullish MACD crossover, explaining why RDNT maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$56.85
Potential Upside
5%
Whystock Fair Value$59.69
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus8 analysts
Mean target$89.88+58.1%
Range$70.00 – $100.00
Fundamentals
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.53B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.53
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.71%
Volume
Today's trading volume
612,719
Recent News
A Look At RadNet (RDNT) Valuation As Idaho Joint Venture Expands Its AI Imaging Network
Idaho joint venture puts RadNet’s AI tools to work RadNet (RDNT) has moved into Idaho through a new joint venture with Saint Alphonsus Health System, taking a majority stake in Intermountain Medical Imaging and its five outpatient imaging centers around Boise. The arrangement puts RadNet in charge of operating these centers while Gem State Radiology continues to handle readings and reports, now supported by DeepHealth’s AI-powered software across diagnostics, reporting, and day to day...
Is RadNet, Inc. (RDNT) A Good Stock To Buy Now?
Is RDNT a good stock to buy? We came across a bearish thesis on RadNet, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bears’ thesis on RDNT. RadNet, Inc.’s share was trading at $57.85 as of April 20th. RDNT’s trailing P/E was 386.89 according to Yahoo Finance. RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services […]
3 Small-Cap Stocks We’re Skeptical Of
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
GE HealthCare (GEHC), RadNet’s DeepHealth Expand AI-Powered Breast Cancer Screening Collaboration
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the 10 Hidden AI Stocks to Invest In. GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the hidden AI stocks to invest in. On April 16, GE HealthCare expanded its collaboration with RadNet’s subsidiary, DeepHealth, to increase global access to AI-powered breast cancer screening technologies. This partnership […]
GEHC & DeepHealth Advance AI Breast Cancer Screening Globally
GE HealthCare expands DeepHealth tie-up to roll out AI-powered mammography tools, improving early breast cancer detection and advancing women's health.